Search

everythinglearnresearchcommunity

for

Search:↓

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Children with cancer had slightly more unusual facial shapes than healthy kids, but not enough to easily tell them apart.

Onions may help reduce cancer risk and obesity-related issues.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Haircuts and medical growth factors do not cause cancer.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Physical activity, height, and smoking affect prostate cancer risk.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

Non-melanoma skin cancer in darker-skinned people can be misdiagnosed, so doctors need to be more aware to diagnose it correctly and early.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Docetaxel treatment for breast cancer can cause permanent hair loss.